How Valeant is changing the Pharmaceutical Industry? – Zacks.com


USA TODAY
How Valeant is changing the Pharmaceutical Industry?
Zacks.com
In Apr 2015, the company acquired Salix Pharmaceuticals and added several innovative gastroenterology treatments, including Xifaxan 550 mg, Ruconest, Apriso, Uceris extended release and Relistor, to its portfolio. Moreover, in Aug 2015, Valeant …
Valeant Pharmaceuticals Intl Price Target Cut to $250.00 by Analysts at Dakota Financial News
Valeant Pharmaceuticals (VRX) Receives Federal Subpoenas on Drug PricingInvestorGuide
Healthcare Gainers: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Aoxing Benchmark Monitor
Fortune -Reuters -MarketBeat -Securities and Exchange Commission
all 268 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd